Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
~49 mi.
(Bucharest,
Romania,
+158 more cities)
Spitalul Universitar de Urgenta Bucuresti ( Site 2508)